Company
Origio
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
9
510(k), De Novo and PMA
Device trials
1
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
2
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Origio, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Origio.
Latest FDA decisions
The 8 newest of 9 since 2015.
- Synvitro Hyadase510(k)
K200680 · Decided Jul 17, 2020 · 123 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
- VitriGuard510(k)
K200815 · Decided Jun 25, 2020 · 87 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
- VitriGuard510(k)
K180740 · Decided May 4, 2018 · 43 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
6 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVFPivotal-lookingCompleted
NCT00565747 · 1,332 participants · Start Nov 2007 · Primary completion Nov 2010
Device: Test culture; Control culture · For: Infertility
Sites: Aarhus, Denmark; Brædstrup, Denmark; Copenhagen, Denmark · 14 sites in all
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1946-2014 · Started Jun 20, 2014 · Posted by FDA Jun 30, 2014
Reason given: Identification of packaging breach of the nylon pouch sterile barrier for the 3-pack configuration
Cause as FDA categorized it: Package design/selection · Device type: Labware, Assisted Reproduction (MQK)
Z-1094-2012 · Started Nov 28, 2011 · Posted by FDA Feb 23, 2012
Reason given: Cryopettes were rupturing during the warming process following vitrification.
Cause as FDA categorized it: Device Design · Device type: Labware, Assisted Reproduction (MQK)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.